Skip to main content
Market intelligence
ATAIHealthcare

ATAI Life Sciences N.V insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 7, 2026Robert HershbergDirectorSale100,000$4.96$496,000
Jun 26, 2026Gerd KochendoerferChief Operating OfficerSale50,000$5.00$250,000
Jun 25, 2026Kevin James CraigChief Medical OfficerSale42,579$4.51$192,031